Limbal Relaxing Incision Versus Toric Intraocular Lens for Corneal Astigmatism During Cataract Surgery.

Sponsor
Christin Henein (Other)
Overall Status
Unknown status
CT.gov ID
NCT02067429
Collaborator
Rayner Intraocular Lenses Limited (Industry)
80
1
2

Study Details

Study Description

Brief Summary

This study will compare toric intra-ocular lens (IOL) with limbal relaxing incisions (LRI) in correcting astigmatism in patient undergoing standard cataract surgery.

Astigmatism is unequal curvature of the eye; the eye is oval rather than spherical. Uncorrected astigmatism of greater than approximately 0.75 diopters (D) can cause visual blurring, ghosting of images or halos. Over 20% of patients undergoing cataract surgery have astigmatism which is likely to have been corrected by spectacles.

Cataract surgery involves the replacement of the natural opacifying crystalline lens with a clear artificial plastic intra-ocular lens (IOL). The lens power can be selected to correct the patient's glasses prescription. The most widely used IOLs only correct glasses at one distance i.e. either near or distance. Residual astigmatism after cataract surgery will need glasses for correction which is undesirable for many patients.

Limbal relaxing incisions (LRI) are circumferential partial thickness cuts to the clear window of the eye (cornea) during surgery. These LRIs can correct corneal astigmatism and have no additional risk of complications.

Alternatively, toric IOLs are available which correct astigmatism inside the eye. They have been available for routine use in the last few years; technology has markedly improved and the lenses have become cheaper.

Studies have suggested toric IOLs provide better vision after cataract surgery than the regular IOLs. Toric IOL are widely used in the private practice and increasingly in the National Health Service (NHS). LRIs are cost effective for treating astigmatism however their predictability is believed to be lower than toric IOLs. As there are no randomised controlled trials comparing the outcomes between LRIs and toric IOLs. This research will address this gap in knowledge and accordingly from this research future practice will be able to provide treatment to patients with information about the best outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Limbal Relaxing Incisions
  • Device: Toric Intraocular Lens
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Limbal Relaxing Incisions Versus Toric Intraocular Lens for Keratometric Astigmatism <2.5 Diopters in Patients Undergoing Cataract Surgery and Intraocular Lens Implantation.
Study Start Date :
Jun 1, 2014
Anticipated Primary Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Toric Intraocular lens

Toric intraocular lens implantation during standard cataract surgery

Device: Toric Intraocular Lens

Experimental: Limbal Relaxing Incisions

Limbal relaxing incisions during standard cataract surgery

Procedure: Limbal Relaxing Incisions

Outcome Measures

Primary Outcome Measures

  1. Unaided distance LogMAR visual acuity (UDVA) [1 months]

  2. Unaided distance LogMAR visual acuity (UDVA) [3 months]

  3. Unaided distance LogMAR visual acuity (UDVA) [6 months]

  4. Unaided distance LogMAR visual acuity (UDVA) [12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Symptomatic cataract for which the patient desires surgery

  2. Corneal astigmatism of greater than or equal to 0.75 D and lesser than or equal to 2.5D.

  3. No significant ophthalmic co-morbidity which would affect the postoperative visual outcomes.

Exclusion Criteria:
  1. <18 years of age

  2. Significant ophthalmic comorbidity detrimental to final visual outcomes

  3. Not competent to give consent

  4. Concurrent use of ocular medications including lubricants

  5. Unable to attend follow ups at 1, 3, 6 and 12 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sussex Eye Hospital Brighton United Kingdom BN2 5BF

Sponsors and Collaborators

  • Christin Henein
  • Rayner Intraocular Lenses Limited

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christin Henein, Academic Foundation Doctor, Sussex Eye Hospital
ClinicalTrials.gov Identifier:
NCT02067429
Other Study ID Numbers:
  • RCT135670
First Posted:
Feb 20, 2014
Last Update Posted:
Dec 2, 2014
Last Verified:
Nov 1, 2014
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 2, 2014